Changeflow GovPing Government & Legislation DEA Proposes Rescheduling Marijuana from Schedu...
Priority review Consultation Amended Consultation

DEA Proposes Rescheduling Marijuana from Schedule I to Lower Schedule

Email

Summary

The Drug Enforcement Administration has issued a proposed rule to reschedule marijuana from Schedule I to a lower schedule under the Controlled Substances Act. This unpublished Public Inspection document is scheduled for official publication on 04/28/2026. If finalized, this change would represent a significant reduction in regulatory restrictions on marijuana, affecting cannabis manufacturers, pharmaceutical companies, and other entities in the cannabis supply chain.

“Schedules of Controlled Substances: Rescheduling of Marijuana”

DEA , verbatim from source
Published by DEA on federalregister.gov . Detected, standardized, and enriched by GovPing. Review our methodology and editorial standards .

About this source

GovPing monitors US Federal Register — Public Inspection Desk for new government & legislation regulatory changes. Every update since tracking began is archived, classified, and available as free RSS or email alerts — 38 changes logged to date.

What changed

The DEA has published a Public Inspection document proposing to reschedule marijuana from Schedule I to a lower schedule under the Controlled Substances Act. This would reverse the most restrictive federal classification for cannabis. The document is currently unpublished and available only in pre-publication form on the Federal Register Public Inspection Desk.

Cannabis manufacturers, pharmaceutical companies, and other entities in the cannabis industry should monitor this proposed rule closely. While no compliance obligations arise from this consultation-stage document, finalization would substantially alter the regulatory landscape for controlled substance handling, research, and manufacturing. Entities currently operating under Schedule I compliance frameworks should begin reviewing potential operational impacts.

Archived snapshot

Apr 27, 2026

GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.

Public Inspection :: Proposed Rule

Schedules of Controlled Substances: Rescheduling of Marijuana

An unpublished Proposed Rule
by the Drug Enforcement Administration on 04/28/2026

  • Document Details
  • Sharing Public Inspection Document This document is unpublished. It is scheduled to be published on 04/28/2026.

Once it is published it will be available on this page in an official form.
Until then, you can download the unpublished PDF version.

Although we make a concerted effort to reproduce the original document
in full on our Public Inspection pages, in some cases graphics may not
be displayed, and non-substantive markup language may appear alongside
substantive text. If you are using public inspection listings for legal
research, you should verify the contents of documents against a final,
official edition of the Federal Register. Only official editions of the Federal Register provide legal
notice of publication to the public and judicial notice to the courts under 44 U.S.C. 1503 & 1507.
Learn more here.

Public Inspection Document

Get daily alerts for US Federal Register — Public Inspection Desk

Daily digest delivered to your inbox.

Free. Unsubscribe anytime.

About this page

What is GovPing?

Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission

What's from the agency?

Source document text, dates, docket IDs, and authority are extracted directly from DEA.

What's AI-generated?

The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.

Last updated

Classification

Agency
DEA
Instrument
Consultation
Branch
Executive
Legal weight
Non-binding
Stage
Consultation
Change scope
Substantive

Who this affects

Applies to
Drug manufacturers Pharmaceutical companies Manufacturers
Industry sector
4453 Cannabis 3254 Pharmaceutical Manufacturing
Activity scope
Drug scheduling Controlled substance regulation Regulatory classification
Geographic scope
United States US

Taxonomy

Primary area
Cannabis
Operational domain
Regulatory Affairs
Topics
Public Health Healthcare Pharmaceuticals

Get alerts for this source

We'll email you when US Federal Register — Public Inspection Desk publishes new changes.

Free. Unsubscribe anytime.

You're subscribed!